tirzepatide off patent FDA confirms shortage is still over, gives compounders a grace period Your Questions Answered: Off-patent Semaglutide
Description
Its expected to be launched by Eli Lilly in early 2025
Reconstitute: Add 2.0 mL bacteriostatic water 7.5 mg/mL concentration
Gastrointestinal Disorders: Increased risk of conditions like gastroesophageal reflux disease (GERD) and fatty liver disease
You also get it from food, primarily red meat and dairy products
Gradual Dose Escalation (Titration): Treatment begins at the lowest dose (e.g., 2.5 mg) and is gradually increased every 4 weeks under medical supervision
